Prot #JCAR017-BCM-002: An Exploratory Phase 1/2 Trial to Evaluate the Safety and Efficacy of JCAR017 Combinations in Subjects with Relapsed/Refractory B-Cell Malignancies (PLATFORM)

Project: Research project

Project Details

StatusActive
Effective start/end date4/17/18 → 4/17/24

Funding

  • Celgene Corporation (Prot #JCAR017-BCM-002)
  • Juno Therapeutics, Inc. (Prot #JCAR017-BCM-002)